USA Financial Formulas’s Pfizer PFE Stock Holding History

USA Financial Formulas’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,925	Closed	-$1.47M	–	454
2021 Q4	$1.47M	Buy	24,925 +23,806	+2,127%	+$1.18M	1.26%	31
2021 Q3	$48K	Buy	1,119 +1,079	+2,698%	+$47.8K	0.04%	211
2021 Q2	$2K	Buy	+40	New	+$1.56K	﹤0.01%	321
2019 Q1	–	Sell	-188,390	Closed	-$7.88M	–	281
2018 Q4	$7.88M	Buy	+188,390	New	+$7.82M	1.96%	15
2018 Q3	–	Sell	-85,727	Closed	-$2.89M	–	364
2018 Q2	$2.89M	Sell	85,727 -218	-0.3%	-$7.45K	0.7%	63
2018 Q1	$2.89M	Buy	85,945 +14,321	+20%	+$492K	0.7%	63
2017 Q4	$2.46M	Buy	+71,624	New	+$2.44M	0.59%	73
2016 Q3	–	Sell	-25,791	Closed	-$862K	–	290
2016 Q2	$862K	Buy	+25,791	New	+$823K	0.24%	89
2015 Q3	–	Sell	-451,254	Closed	-$14.4M	–	173
2015 Q2	$14.4M	Buy	+451,254	New	+$14.7M	4.41%	3

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

USA Financial Formulas's PFE Position: Q1 2022 in Review

USA Financial Formulas sold out of Pfizer (PFE) in Q1 2022, closing a stake of 24,925 shares — an estimated $1.47M sold.

USA Financial Formulas first reported a position in PFE in Q2 2015 and held it in 9 quarters. The position peaked at $14.4M in Q2 2015. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

USA Financial Formulas reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
USA Financial Formulas sold 24,925 Pfizer shares in Q1 2022, an estimated $1.47M.
USA Financial Formulas first reported a position in Pfizer in Q2 2015 and held it in 9 quarters.
USA Financial Formulas's Pfizer position peaked at $14.4M in Q2 2015.
3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on USA Financial Formulas's 13F filing for Q1 2022, filed 16 Aug 2022.